Stock search

Ticker or company name

Compare stocks

Market: US

  • IDXXIdexx Laboratories
  • HUMHumana
  • BDXBecton Dickinson

Add stock

Ticker or company

Summary

IDXX
Idexx Laboratories
$700,65Down −0,51%
Year: Up 0%
83/100Best scoreRatio would consider buying
Open stock page
HUM
Humana
$461,25Up +2,50%
Year: Up +90%
61/100Ratio would watch
Open stock page
BDX
Becton Dickinson
$216,47Down −0,72%
Year: Up +44%
38/100Ratio would not consider buying
Open stock page

Verdict

IDXX has the best score (83). HUM grows revenue the fastest. BDX is the cheapest by forward P/E. HUM has the lowest debt load. IDXX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckIDXX7 ✓ 1 — 1 ✕HUM5 ✓ 1 — 3 ✕BDX2 ✓ 2 — 4 ✕
P/E vs its history47,244,051,8
P/E vs industry47,244,051,8
Forward P/E33,526,914,9
Revenue growth, YoY+11,9%+22,0%−2,6%
EPS growth, YoY+17,7%−3,6%−39,4%
Net margin25,4%0,8%4,5%
Net debt / EBITDA0,1−4,52,9
Free cash flow$1,30 bn$3,14 bnn/a—
Share count over a year−2,0%+0,9%−4,2%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterIDXXTTMHUMTTMBDXTTMIndustry medianTTM
P/E TTM ↓47,2Best: 44,0Worst: 51,825,1
Forward P/E ↓Worst: 33,526,9Best: 14,916,2
PEG ↓Worst: 2,8Best: 1,9−27,12,2
P/S TTM ↓Worst: 12,0Best: 0,42,92,2
EV/EBITDA ↓Worst: 33,920,0Best: 16,417,3
P/FCF ↓Worst: 42,9Best: 11,021,519,5

Price, %

  • IDXXn/a
  • HUMn/a
  • BDXn/a

Returns

Best WorstNo mark — in between

PeriodIDXXHUMBDX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

IDXXHUMBDX
Share of “buy”Best: 67%59%Worst: 57%
Beat the forecast4 of 44 of 44 of 4
Average “surprise”+3,7%Best: +9,4%Worst: +2,2%
Insiders over 12 monthssales $58,4 msales $2,43 msales $3,38 m

Details are on each stock page.